Jade Biosciences, Inc. Common Stock (JBIO) Q4 2024 Annual Earnings
JBIO·Reported March 27, 2025·Before market open
Diluted EPS came in at $-0.19.
Diluted EPS
$-0.19met estimate
Consensus: $-0.19
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Jade Biosciences, Inc. Common Stock's Q4 2024 earnings report.
Jade Biosciences, Inc. Common Stock (JBIO) reported Q4 2024 earnings on March 27, 2025 before market open.
Jade Biosciences, Inc. Common Stock reported diluted EPS of $-0.19 for Q4 2024.
EPS beat the consensus estimate of $-0.19 by $0.00.
You can read the 10-K periodic report (0001558370-25-003750) directly on SEC EDGAR. The filing index links above go to sec.gov.